“…The treatment of ST-ⅡAS can also effectively reduce the FMD level after treatment and improve the vascular endothelial relaxation function. At the same time, the observation group's overall effective rate was 94.44% higher than the general group's (P<0.05); Research shows that ST-ⅡAS has a potential therapeutic effect on ischemic cerebral infarction, can improve the proteomics of the cerebral infarction site, and help improve the neurological function (15,16). Based on the similarity of cardio-cerebrovascular diseases, we can speculate that ST-ⅡAS can have beneficial effects on cardiovascular proteomics.…”